NCT05208047 2026-02-04(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal TumorsCogent Biosciences, Inc.Phase 3 Active not recruiting442 enrolled
NCT04908176 2024-12-13A Drug-drug Interaction Study of Avapritinib and MidazolamBlueprint Medicines CorporationPhase 1 Completed10 enrolled
NCT01402089 2016-02-02Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer PatientsCantonal Hospital of St. GallenPhase 4 Completed54 enrolled